Cancer Communications is a high-impact journal devoted to advancing understanding of cancer biology and improving patient outcomes. With a focus on promoting interdisciplinary collaboration, this international journal serves as a platform for researchers and clinicians. The journal covers a wide range of topics, including cancer genetics, genomics, tumor microenvironment, immunotherapy, and innovative therapeutic strategies. Cancer Communications publishes original research articles, reviews, and perspectives that contribute to the understanding of cancer biology, diagnosis, prevention, and treatment.
Indexed in major databases like CAS, Scopus, and Web of Science, Cancer Communications aims to disseminate high-quality research to a global audience, including oncologists, cancer biologists, and researchers in related fields. The journal also highlights advancements in basic, translational, and clinical research, bridging the gap between laboratory discoveries and patient care. It provides insights for both experienced researchers and early-career scientists, as well as medical professionals involved in oncology care.
Cancer Communications promotes open access to research and invites submissions from researchers working on different types of cancers and therapeutic interventions. By providing a platform for scientific discussion, the journal contributes to the development of new approaches to combating cancer and improving patient care. This is achieved through regular publications, comprehensive analysis, and exploration of therapeutic targets.